Our approach to safety

Safety and quality are the foundation of apo.

Discover what apo is designed to do, how it’s regulated, and how we monitor safety.

apo’s intended use

Intended use means the purpose the product is designed for, the type of support it provides, who should use it, and the conditions it’s meant to help with.

apo’s specific intended use statement for classification as a medical device is:

The Apo software is intended to support adult users in understanding and self-managing musculoskeletal health through the provision of educational content, guided exercises, and wellbeing resources. The software is intended to support self-management and user engagement with musculoskeletal health alongside standard care. The software does not diagnose medical conditions, determine treatment, or replace clinical judgment.

Find out more

Is apo a medical device?

Yes. apo is registered with the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a Class I medical device and is CE-marked.

What does Class I mean?

A Class I medical device is considered low risk. Even so, it must be developed and maintained with clear safety and quality processes, and we are required to monitor apo after it’s on the market.

What does - and doesn’t - apo do?

apo is designed to:

  • help you plan and manage your MSK care

  • provide guidance to support improvement over time

  • help you develop practical care strategies you can stick with.

apo is not designed to:

  • provide emergency care

  • diagnose a medical condition

  • replace advice or treatment from a qualified clinician

If you’re worried about your symptoms, they suddenly worsen, or you think you may need urgent help, seek medical advice from a care professional.

How we keep apo safe

We build apo with structured safety controls, including:

  • risk management to identify and reduce potential harms 

  • clinical governance oversight of safety and effectiveness monitoring 

  • post-market surveillance to continuously check real-world performance and improve over time

How we monitor safety after launch

Safety doesn’t stop at release. We run an ongoing Post-Market Surveillance (PMS) process to collect and review information about apo’s performance and user experience. 

What we monitor

We review signals such as:

  • user feedback (surveys, interviews, feedback forms) 

  • adverse events (any undesirable experiences linked to use) 

  • clinical and wellbeing measures (tracked over time at a group level, e.g., pain, sleep, stress/wellbeing, function) 

  • product performance and reliability (crash reports, error logs, usage patterns) 

  • cybersecurity (including ongoing security testing) 

How we use this information

We use structured review methods to:

  • spot trends (e.g., emerging usability problems) 

  • investigate issues (including root-cause analysis where needed) 

  • take action (corrective and preventive actions) and verify the fix works 

How often we review

We formally review PMS data monthly to identify trends, with urgent issues handled as they arise.

Reporting serious issues

If there is a serious incident, we follow regulatory processes, including reporting to the MHRA when required.

Report a problem or share feedback

If you think apo has caused harm, could cause harm, or you’ve found a safety or security issue, please tell email support@myapocare.com


Remember: If you think you’re having a medical emergency, call 999.